LOL all these people want to focus on me instead of the plummeting share price from the match. That should give everyone a nice big red flag for the quality of investors involved in this company.
Thanks for the short, this has made my week so far. Any further breakdown and it might just make my whole month.
It's common sense that having only 11 patients in a phase 2 trial is TERRIBLE. Enjoy your gap up, if you had a clue you'd probably have taken profits on this silly gap up, take advantage of the mistakes of amateurs.
Ann: Phase 2 trial shows significant improvements in Pitt Hopkins, page-43
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |